TY - JOUR
T1 - Improvement in Functional Outcomes Following Ileal Pouch-Anal Anastomosis
T2 - Results from the United States Ileal Pouch-Anal Anastomosis Study
AU - Zuckerman, Jesse
AU - De Buck Van Overstraeten, Anthony
AU - Melmed, Gil Y.
AU - Mustain, William Conan
AU - Scow, Jeffrey S.
AU - Otterson, Mary
AU - Ogilvie, James
AU - Bordeianou, Liliana
AU - Brar, Mantaj
AU - Wells, Katerina
AU - Ovsepyan, Gayane
AU - Mirocha, James
AU - Holubar, Stefan D.
AU - Wexner, Steven
AU - Hyman, Neil
AU - Fleshner, Phillip
AU - Zaghiyan, Karen
N1 - Publisher Copyright:
© 2025 Lippincott Williams and Wilkins. All rights reserved.
PY - 2025
Y1 - 2025
N2 - BACKGROUND: Ileal pouch-anal anastomosis is the standard procedure for patients with ulcerative colitis or unclassified inflammatory bowel disease seeking intestinal continuity post-proctocolectomy. Previous studies on function are limited by retrospective design, single-center scope, and insufficient functional domain data. OBJECTIVE: To provide prospective, multicenter data on functional outcomes after ileal pouch-anal anastomosis. DESIGN: Prospective cohort study. SETTINGS: Several North American centers. PATIENTS: Adults scheduled for ileal pouch-anal anastomosis between June 2018 and June 2022. MAIN OUTCOME MEASURES: Patient-reported colorectal (COREFO, Wexner Fecal Incontinence), sexual (PROMIS Sex-FS), urinary (International Prostate Symptom Score), and global (PROMIS Global-10) function. RESULTS: A total of 203 patients were included (mean age, 35.8 ± 13.4, 59% male). Most had UC (95%) with refractory disease the most common surgical indication (91%). Fifty-seven patients (28%) had subtotal colectomy without ileal pouch-anal anastomosis. Bowel function improved significantly after ileal pouch-anal anastomosis (COREFO mean, 50.6 ± 18.8 at baseline to 24.3 ± 17.7 at 12 months, p < 0.0001; Wexner mean 8.2 ± 5.3 at baseline to 4.3 ± 4.5 at 12 months, p < 0.0001) as did global health satisfaction (mental health mean T-score 41.5±10.8 at baseline to 51.2 ± 10.3 at 12 months, p < 0.0001; physical health mean T-score 39.2±9.2 at baseline to 52.2 ± 9.2 at 12 months, p < 0.0001). Sexual interest increased for both females (mean T-score, 34.2 ± 13.2 at baseline to 41.9 ± 13.0 at 12 months, p = 0.007) and males (mean T-score, 39.4 ± 13.8 at baseline to 51.1 ± 9.6 at 12 months, p < 0.0001); other sexual domains were stable. Urinary function remained stable (mean, 7.2 ± 6.3 at baseline to 5.4 ± 6.3 at 12 months, p = 0.08). Surgical indication significantly associated with postoperative bowel function (p = 0.0003). LIMITATIONS: Sample size is limited; follow-up limited to 12 months. CONCLUSION: In this prospective multicenter cohort, ileal pouch-anal anastomosis led to significant improvements in bowel function, continence, sexual interest, and overall health, with no decline in urinary or other sexual functions. These findings support the role of ileal pouch-anal anastomosis in restoring function and inform preoperative counseling and decision-making.
AB - BACKGROUND: Ileal pouch-anal anastomosis is the standard procedure for patients with ulcerative colitis or unclassified inflammatory bowel disease seeking intestinal continuity post-proctocolectomy. Previous studies on function are limited by retrospective design, single-center scope, and insufficient functional domain data. OBJECTIVE: To provide prospective, multicenter data on functional outcomes after ileal pouch-anal anastomosis. DESIGN: Prospective cohort study. SETTINGS: Several North American centers. PATIENTS: Adults scheduled for ileal pouch-anal anastomosis between June 2018 and June 2022. MAIN OUTCOME MEASURES: Patient-reported colorectal (COREFO, Wexner Fecal Incontinence), sexual (PROMIS Sex-FS), urinary (International Prostate Symptom Score), and global (PROMIS Global-10) function. RESULTS: A total of 203 patients were included (mean age, 35.8 ± 13.4, 59% male). Most had UC (95%) with refractory disease the most common surgical indication (91%). Fifty-seven patients (28%) had subtotal colectomy without ileal pouch-anal anastomosis. Bowel function improved significantly after ileal pouch-anal anastomosis (COREFO mean, 50.6 ± 18.8 at baseline to 24.3 ± 17.7 at 12 months, p < 0.0001; Wexner mean 8.2 ± 5.3 at baseline to 4.3 ± 4.5 at 12 months, p < 0.0001) as did global health satisfaction (mental health mean T-score 41.5±10.8 at baseline to 51.2 ± 10.3 at 12 months, p < 0.0001; physical health mean T-score 39.2±9.2 at baseline to 52.2 ± 9.2 at 12 months, p < 0.0001). Sexual interest increased for both females (mean T-score, 34.2 ± 13.2 at baseline to 41.9 ± 13.0 at 12 months, p = 0.007) and males (mean T-score, 39.4 ± 13.8 at baseline to 51.1 ± 9.6 at 12 months, p < 0.0001); other sexual domains were stable. Urinary function remained stable (mean, 7.2 ± 6.3 at baseline to 5.4 ± 6.3 at 12 months, p = 0.08). Surgical indication significantly associated with postoperative bowel function (p = 0.0003). LIMITATIONS: Sample size is limited; follow-up limited to 12 months. CONCLUSION: In this prospective multicenter cohort, ileal pouch-anal anastomosis led to significant improvements in bowel function, continence, sexual interest, and overall health, with no decline in urinary or other sexual functions. These findings support the role of ileal pouch-anal anastomosis in restoring function and inform preoperative counseling and decision-making.
UR - https://www.scopus.com/pages/publications/105011638804
UR - https://www.scopus.com/pages/publications/105011638804#tab=citedBy
U2 - 10.1097/DCR.0000000000003894
DO - 10.1097/DCR.0000000000003894
M3 - Article
C2 - 40698674
AN - SCOPUS:105011638804
SN - 0012-3706
JO - Diseases of the colon and rectum
JF - Diseases of the colon and rectum
M1 - 10.1097/DCR.0000000000003894
ER -